In this setting, patients with DNMT overexpression were characterized by aggressive disease and poor prognosis, probably in relation to the hypermethylation of important genes in homeostasis although no target gene have been clearly identified in AML. The gene discussed is DNMT1; the disease is acute myeloid leukemia.